TY - JOUR AU - Brechot, C. PY - 2004 DA - 2004// TI - Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms JO - Gastroenterology VL - 127 UR - https://doi.org/10.1053/j.gastro.2004.09.016 DO - 10.1053/j.gastro.2004.09.016 ID - Brechot2004 ER - TY - JOUR AU - Chisari, F. V. AU - Isogawa, M. AU - Wieland, S. F. PY - 2010 DA - 2010// TI - Pathogenesis of hepatitis B virus infection JO - Pathol Biol VL - 58 UR - https://doi.org/10.1016/j.patbio.2009.11.001 DO - 10.1016/j.patbio.2009.11.001 ID - Chisari2010 ER - TY - JOUR AU - Guidotti, L. G. AU - Chisari, F. V. PY - 2006 DA - 2006// TI - Immunobiology and pathogenesis of viral hepatitis JO - Annu Rev Pathol VL - 1 UR - https://doi.org/10.1146/annurev.pathol.1.110304.100230 DO - 10.1146/annurev.pathol.1.110304.100230 ID - Guidotti2006 ER - TY - JOUR AU - Seeger, C. AU - Ganem, D. AU - Harold, E. V. PY - 1986 DA - 1986// TI - Biochemical and genetic evidence for the hepatitis B virus replication strategy JO - Science VL - 232 UR - https://doi.org/10.1126/science.3961490 DO - 10.1126/science.3961490 ID - Seeger1986 ER - TY - JOUR AU - Dienstag, J. L. PY - 2008 DA - 2008// TI - Hepatitis B Virus Infection JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMra0801644 DO - 10.1056/NEJMra0801644 ID - Dienstag2008 ER - TY - JOUR AU - Delaney, W. E. AU - Yang, H. AU - Westland, C. E. AU - Das, K. AU - Arnold, E. AU - Gibbs, C. S. PY - 2003 DA - 2003// TI - The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.21.11833-11841.2003 DO - 10.1128/JVI.77.21.11833-11841.2003 ID - Delaney2003 ER - TY - JOUR AU - Shaw, T. AU - Bartholomeusz, A. AU - Locarnini, S. PY - 2006 DA - 2006// TI - HBV drug resistance: mechanisms, detection and interpretation JO - J Hepatol VL - 44 UR - https://doi.org/10.1016/j.jhep.2006.01.001 DO - 10.1016/j.jhep.2006.01.001 ID - Shaw2006 ER - TY - JOUR AU - Zoulim, F. AU - Locarnini, S. PY - 2009 DA - 2009// TI - Hepatitis B Virus Resistance to Nucleos(t)ide Analogues JO - Gastroenterology VL - 137 UR - https://doi.org/10.1053/j.gastro.2009.08.063 DO - 10.1053/j.gastro.2009.08.063 ID - Zoulim2009 ER - TY - JOUR AU - Ono-Nita, S. K. AU - Kato, N. AU - Shiratori, Y. AU - Masaki, T. AU - Lan, K. H. AU - Carrilho, F. J. PY - 1999 DA - 1999// TI - YMDD Motif in Hepatitis B Virus DNA Polymerase Influences on Replication and Lamivudine Resistance: A Study by In Vitro Full-Length Viral DNA Transfection JO - Hepatology VL - 29 UR - https://doi.org/10.1002/hep.510290340 DO - 10.1002/hep.510290340 ID - Ono-Nita1999 ER - TY - JOUR AU - Niesters, H. G. AU - Man, R. A. AU - Pas, S. D. AU - Fries, E. AU - Osterhaus, A. D. PY - 2002 DA - 2002// TI - Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy JO - J Med Microbiol VL - 51 UR - https://doi.org/10.1099/0022-1317-51-8-695 DO - 10.1099/0022-1317-51-8-695 ID - Niesters2002 ER - TY - JOUR AU - Bozdayi, A. M. AU - Uzunalimoglu, O. AU - Turkyılmaz, A. R. AU - Aslan, N. AU - Aslan, N. AU - Sezgin, O. PY - 2003 DA - 2003// TI - YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine JO - J Viral Hepat VL - 10 UR - https://doi.org/10.1046/j.1365-2893.2003.00435.x DO - 10.1046/j.1365-2893.2003.00435.x ID - Bozdayi2003 ER - TY - JOUR AU - Ogata, N. AU - Fujii, K. AU - Takigawa, S. AU - Nomoto, M. AU - Ichida, T. AU - Asakura, H. PY - 1999 DA - 1999// TI - Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B JO - J Med Virol VL - 59 UR - https://doi.org/3.0.CO;2-1 DO - 3.0.CO;2-1 ID - Ogata1999 ER - TY - JOUR AU - Chong, Y. AU - Stuyver, L. AU - Otto, M. J. AU - Schinazi, R. F. AU - Chu, C. K. PY - 2003 DA - 2003// TI - Mechanism of antiviral activities of 3′-substituted L-nucleosides against 3TC resistant HBV polymerase: a molecular modelling approach JO - Antivir Chem Chemother VL - 14 UR - https://doi.org/10.1177/095632020301400603 DO - 10.1177/095632020301400603 ID - Chong2003 ER - TY - JOUR AU - Villeneuve, J. -. P. AU - Durantel, D. AU - Durantel, S. AU - Westland, C. AU - Xiong, S. AU - Brosgart, C. L. PY - 2003 DA - 2003// TI - Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient JO - J Hepatol VL - 39 UR - https://doi.org/10.1016/j.jhep.2003.09.022 DO - 10.1016/j.jhep.2003.09.022 ID - Villeneuve2003 ER - TY - JOUR AU - Lee, Y. S. AU - Chung, Y. H. AU - Kim, J. A. AU - Kim, S. E. AU - Shin, J. W. AU - Kim, K. M. PY - 2009 DA - 2009// TI - Hepatitis B virus with rtL80V/I mutation associates with poor response to adefovir dipivoxil therapy JO - Liver Int VL - 29 UR - https://doi.org/10.1111/j.1478-3231.2008.01882.x DO - 10.1111/j.1478-3231.2008.01882.x ID - Lee2009 ER - TY - JOUR AU - Tenney, D. J. AU - Levine, S. M. AU - Rose, R. E. AU - Walsh, A. W. AU - Weinheimer, S. P. AU - Discotto, L. PY - 2004 DA - 2004// TI - Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.9.3498-3507.2004 DO - 10.1128/AAC.48.9.3498-3507.2004 ID - Tenney2004 ER - TY - JOUR AU - Yanni, Y. N. AU - Henry, L. Y. PY - 2008 DA - 2008// TI - A review of telbivudine for the management of chronic hepatitis B virus infection JO - Drug Eval VL - 4 ID - Yanni2008 ER - TY - JOUR AU - Yuen, M. F. AU - Lai, C. L. PY - 2004 DA - 2004// TI - Adefovir dipivoxil in chronic hepatitis B infection JO - Expert Opin Pharmacother VL - 5 UR - https://doi.org/10.1517/14656566.5.11.2361 DO - 10.1517/14656566.5.11.2361 ID - Yuen2004 ER - TY - JOUR AU - Bömmel, F. AU - Zöllner, B. AU - Sarrazin, C. AU - Spengler, U. AU - Hüppe, D. AU - Möller, B. PY - 2006 DA - 2006// TI - Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy JO - Hepatology VL - 44 UR - https://doi.org/10.1002/hep.21253 DO - 10.1002/hep.21253 ID - Bömmel2006 ER - TY - JOUR AU - Delmas, J. AU - Schorr, O. AU - Jamard, C. AU - Gibbs, C. AU - Trépo, C. AU - Hantz, O. PY - 2002 DA - 2002// TI - Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.2.425-433.2002 DO - 10.1128/AAC.46.2.425-433.2002 ID - Delmas2002 ER - TY - JOUR AU - King, R. W. AU - Ladner, S. K. AU - Miller, T. J. AU - Zaifert, K. AU - Perni, R. B. AU - Conway, S. C. PY - 1998 DA - 1998// TI - Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (−)b-L- 2′,3′-dideoxy-3′-thiacytidine JO - Antimicrob Agents Chemother VL - 42 ID - King1998 ER - TY - JOUR AU - Delaney, W. E. AU - Edwards, R. AU - Colledge, D. AU - Shaw, T. AU - Furman, P. AU - Painter, G. PY - 2002 DA - 2002// TI - Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.9.3057-3060.2002 DO - 10.1128/AAC.46.9.3057-3060.2002 ID - Delaney2002 ER - TY - JOUR AU - Wang, G. F. AU - Shi, L. P. AU - Zuo, J. P. PY - 2008 DA - 2008// TI - Anti-hepatitis B virus drugs in clinical and preclinical development JO - Virol Sin VL - 2 UR - https://doi.org/10.1007/s12250-008-2945-8 DO - 10.1007/s12250-008-2945-8 ID - Wang2008 ER - TY - JOUR AU - Weber, O. AU - Schlemmer, K. H. AU - Hartmann, E. AU - Hagelschuer, I. AU - Paessens, A. AU - Graef, E. PY - 2002 DA - 2002// TI - Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model JO - Antiviral Res VL - 54 UR - https://doi.org/10.1016/S0166-3542(01)00216-9 DO - 10.1016/S0166-3542(01)00216-9 ID - Weber2002 ER - TY - JOUR AU - Deres, K. AU - Schroder, C. H. AU - Paessens, A. AU - Goldmann, S. AU - Hacker, H. J. AU - Weber, O. PY - 2003 DA - 2003// TI - Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids JO - Science VL - 299 UR - https://doi.org/10.1126/science.1077215 DO - 10.1126/science.1077215 ID - Deres2003 ER - TY - JOUR AU - Weinberg, M. S. AU - Arbuthnot, P. PY - 2010 DA - 2010// TI - Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection JO - Genome Med VL - 2 UR - https://doi.org/10.1186/gm149 DO - 10.1186/gm149 ID - Weinberg2010 ER - TY - JOUR AU - Ely, A. AU - Naidoo, T. AU - Mufamadi, S. AU - Crowther, C. AU - Arbuthnot, P. PY - 2008 DA - 2008// TI - Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo JO - Mol Ther VL - 16 UR - https://doi.org/10.1038/mt.2008.82 DO - 10.1038/mt.2008.82 ID - Ely2008 ER - TY - JOUR AU - Iwamoto, M. AU - Watashi, K. AU - Tsukuda, S. AU - Aly, H. H. AU - Fukasawa, M. AU - Fujimoto, A. PY - 2014 DA - 2014// TI - Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP JO - Biochem Biophys Res Commun VL - 17 UR - https://doi.org/10.1016/j.bbrc.2013.12.052 DO - 10.1016/j.bbrc.2013.12.052 ID - Iwamoto2014 ER - TY - JOUR AU - Wang, G. F. AU - Shia, L. P. AU - Ren, Y. D. AU - Liu, Q. F. AU - Liu, H. F. AU - Zhang, R. J. PY - 2009 DA - 2009// TI - Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro JO - Antiviral Res VL - 83 UR - https://doi.org/10.1016/j.antiviral.2009.05.002 DO - 10.1016/j.antiviral.2009.05.002 ID - Wang2009 ER - TY - JOUR AU - Kim, H. J. AU - Yoo, H. S. AU - Kim, J. C. AU - Park, C. S. AU - Choi, M. S. AU - Kim, M. PY - 2009 DA - 2009// TI - Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication JO - J Ethnopharmacol VL - 124 UR - https://doi.org/10.1016/j.jep.2009.04.046 DO - 10.1016/j.jep.2009.04.046 ID - Kim2009 ER - TY - JOUR AU - Zhao, G. AU - Yin, Z. AU - Dong, J. PY - 2009 DA - 2009// TI - Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum. J JO - J Ethnopharmacol VL - 125 UR - https://doi.org/10.1016/j.jep.2009.06.030 DO - 10.1016/j.jep.2009.06.030 ID - Zhao2009 ER - TY - JOUR AU - Shuangsuo, D. AU - Zhengguo, Z. AU - Yunru, C. AU - Xin, Z. AU - Baofeng, W. AU - Lichao, Y. PY - 2006 DA - 2006// TI - Inhibition of the replication of hepatitis B virus in vitro by emodin JO - Med Sci Monit VL - 12 ID - Shuangsuo2006 ER - TY - JOUR AU - Wu, X. N. AU - Wang, G. J. PY - 2004 DA - 2004// TI - Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections JO - Chin J Dig Dis VL - 5 UR - https://doi.org/10.1111/j.1443-9573.2004.00146.x DO - 10.1111/j.1443-9573.2004.00146.x ID - Wu2004 ER - TY - JOUR AU - Guo, Q. AU - Zhao, L. AU - You, Q. AU - Yang, Y. AU - Gu, H. AU - Song, G. PY - 2007 DA - 2007// TI - Anti-hepatitis B virus activity of wogonin in vitro and in vivo JO - Antiviral Res VL - 74 UR - https://doi.org/10.1016/j.antiviral.2007.01.002 DO - 10.1016/j.antiviral.2007.01.002 ID - Guo2007 ER - TY - JOUR AU - Penolazzi, L. AU - Lampronti, I. AU - Borgatti, M. AU - Khan, M. T. AU - Zennaro, M. AU - Piva, R. PY - 2008 DA - 2008// TI - Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis JO - BMC Complement Altern Med VL - 30 UR - https://doi.org/10.1186/1472-6882-8-59 DO - 10.1186/1472-6882-8-59 ID - Penolazzi2008 ER - TY - JOUR AU - Kusirisin, W. AU - Srichairatanakool, S. AU - Lerttrakarnnon, P. PY - 2009 DA - 2009// TI - Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients JO - Med Chem VL - 5 UR - https://doi.org/10.2174/157340609787582918 DO - 10.2174/157340609787582918 ID - Kusirisin2009 ER - TY - JOUR AU - Ogata, T. AU - Higuchi, H. AU - Mochida, S. PY - 1992 DA - 1992// TI - HIV-1 reverse transcriptase inhibitor from Phyllanthus niruri JO - AIDS Res Hum Retroviruses VL - 8 UR - https://doi.org/10.1089/aid.1992.8.1937 DO - 10.1089/aid.1992.8.1937 ID - Ogata1992 ER - TY - JOUR AU - Venkateswaran, P. S. AU - Millman, I. AU - Blumberg, B. S. PY - 1987 DA - 1987// TI - Effect of extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis Viruses: In vitro and in vivo studies JO - Proc Natl Acad Sci U S A VL - 84 UR - https://doi.org/10.1073/pnas.84.1.274 DO - 10.1073/pnas.84.1.274 ID - Venkateswaran1987 ER - TY - JOUR AU - Ott, M. AU - Thyagarajan, S. P. AU - Gupta, S. PY - 1997 DA - 1997// TI - Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors JO - Eur J Clin Invest VL - 27 UR - https://doi.org/10.1046/j.1365-2362.1997.2020749.x DO - 10.1046/j.1365-2362.1997.2020749.x ID - Ott1997 ER - TY - JOUR AU - Lee, C. D. AU - Ott, M. AU - Thyagarajan, S. P. AU - Shafritz, D. A. AU - Burk, R. D. AU - Gupta, S. PY - 1996 DA - 1996// TI - Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication JO - Eur J Clin Invest VL - 26 UR - https://doi.org/10.1046/j.1365-2362.1996.410595.x DO - 10.1046/j.1365-2362.1996.410595.x ID - Lee1996 ER - TY - JOUR AU - Lam, W. Y. AU - Leung, K. T. AU - Law, P. T. AU - Lee, S. M. AU - Chan, H. L. AU - Fung, K. P. PY - 2006 DA - 2006// TI - Antiviral Effect of Phyllanthus nanus Ethanolic Extract Against Hepatitis B Virus (HBV) by Expression Microarray Analysis JO - J Cell Biochem VL - 97 UR - https://doi.org/10.1002/jcb.20611 DO - 10.1002/jcb.20611 ID - Lam2006 ER - TY - JOUR AU - Shin, M. S. AU - Kang, E. H. AU - Lee, Y. I. PY - 2005 DA - 2005// TI - A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes JO - Antiviral Res VL - 67 UR - https://doi.org/10.1016/j.antiviral.2005.06.005 DO - 10.1016/j.antiviral.2005.06.005 ID - Shin2005 ER - TY - JOUR AU - Kim, H. Y. AU - Park, G. S. AU - Kim, E. G. AU - Kang, S. H. AU - Shin, H. J. AU - Park, S. PY - 2004 DA - 2004// TI - Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle JO - Virology VL - 322 UR - https://doi.org/10.1016/j.virol.2004.01.009 DO - 10.1016/j.virol.2004.01.009 ID - Kim2004 ER - TY - JOUR AU - Mahdi, E. S. AU - Noor, A. M. AU - Sakeena, M. H. AU - Abdullah, G. Z. AU - Abdulkarim, M. AU - Sattar, M. A. PY - 2011 DA - 2011// TI - Identification of phenolic compounds and assessment of in vitro antioxidants activity of 30 % ethanolic extracts derived from two Phyllanthus species indigenous to Malaysia JO - Afr J Pharm Pharmacol VL - 5 ID - Mahdi2011 ER - TY - JOUR AU - Calixto, J. B. AU - Santos, A. R. AU - Cechinel Filho, V. AU - Yunes, R. A. PY - 1998 DA - 1998// TI - A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential JO - Med Res Rev VL - 18 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Calixto1998 ER - TY - JOUR AU - Kim, H. -. Y. AU - Eo, E. -. Y. AU - Park, H. P. AU - Kim, Y. C. AU - Park, S. AU - Shin, H. J. PY - 2010 DA - 2010// TI - Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro JO - Antivir Ther VL - 15 UR - https://doi.org/10.3851/IMP1615 DO - 10.3851/IMP1615 ID - Kim2010 ER - TY - JOUR AU - Sharma, M. AU - Anderson, S. A. AU - Schoop, R. AU - Hudson, J. B. PY - 2009 DA - 2009// TI - Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract JO - Antiviral Res VL - 83 UR - https://doi.org/10.1016/j.antiviral.2009.04.009 DO - 10.1016/j.antiviral.2009.04.009 ID - Sharma2009 ER - TY - JOUR AU - Keskinen, P. AU - Nyqvist, M. AU - Sareneva, T. AU - Pirhonen, J. AU - Melean, K. AU - Julkunen, I. PY - 1999 DA - 1999// TI - Impaired Antiviral Response in Human Hepatoma Cells JO - Virology VL - 263 UR - https://doi.org/10.1006/viro.1999.9983 DO - 10.1006/viro.1999.9983 ID - Keskinen1999 ER - TY - JOUR AU - Biermer, M. AU - Puro, R. AU - Schneider, R. J. PY - 2003 DA - 2003// TI - Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.7.4033-4042.2003 DO - 10.1128/JVI.77.7.4033-4042.2003 ID - Biermer2003 ER - TY - JOUR AU - Tanaka, Y. AU - Marusawa, H. AU - Seno, H. AU - Matsumoto, Y. AU - Ueda, Y. AU - Kodama, Y. PY - 2006 DA - 2006// TI - Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes JO - Biochem Biophys Res Commun VL - 341 UR - https://doi.org/10.1016/j.bbrc.2005.12.192 DO - 10.1016/j.bbrc.2005.12.192 ID - Tanaka2006 ER - TY - JOUR AU - Soulat, D. AU - Burckstummer, T. AU - Westermayer, S. AU - Goncalves, A. AU - Bauch, A. AU - Stefanovic, A. PY - 2008 DA - 2008// TI - The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response JO - EMBO J VL - 27 UR - https://doi.org/10.1038/emboj.2008.126 DO - 10.1038/emboj.2008.126 ID - Soulat2008 ER - TY - JOUR AU - Kock, J. AU - Blum, H. E. PY - 2008 DA - 2008// TI - Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H JO - J Gen Virol VL - 89 UR - https://doi.org/10.1099/vir.0.83507-0 DO - 10.1099/vir.0.83507-0 ID - Kock2008 ER - TY - JOUR AU - Wang, H. AU - Kim, S. H. AU - Ryu, W. S. PY - 2009 DA - 2009// TI - DDX3 DEAD-Box RNA Helicase Inhibits Hepatitis B Virus Reverse Transcription by Incorporation into Nucleocapsids JO - J Virol VL - 83 UR - https://doi.org/10.1128/JVI.00011-09 DO - 10.1128/JVI.00011-09 ID - Wang2009 ER - TY - JOUR AU - Lara-Pezzi, E. AU - Gomez-Gaviro, M. V. AU - Galvez, B. G. AU - Mira, E. AU - Iniguez, M. A. AU - Fresnon, M. PY - 2002 DA - 2002// TI - The hepatitis B virus X protein promoter tumor cell invasion by inducing membrane type matrix metalloproteinase-1 and cyclooxygenase-2 expression JO - J Clin Invest VL - 110 UR - https://doi.org/10.1172/JCI200215887 DO - 10.1172/JCI200215887 ID - Lara-Pezzi2002 ER - TY - JOUR AU - Cho, H. K. AU - Cheong, K. J. AU - Kim, H. Y. AU - Cheong, J. H. PY - 2011 DA - 2011// TI - Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4 JO - Biochem J VL - 435 UR - https://doi.org/10.1042/BJ20102071 DO - 10.1042/BJ20102071 ID - Cho2011 ER - TY - JOUR AU - Corasaniti, M. T. AU - Bellizzi, C. AU - Russo, R. AU - Colica, C. AU - Amantea, D. AU - Rezo, G. D. PY - 2003 DA - 2003// TI - Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells JO - Toxicol Lett VL - 139 UR - https://doi.org/10.1016/S0378-4274(02)00436-8 DO - 10.1016/S0378-4274(02)00436-8 ID - Corasaniti2003 ER - TY - JOUR AU - Hung, J. -. H. AU - Su, I. -. J. AU - Lei, H. -. Y. AU - Wang, H. -. C. AU - Lin, W. -. C. AU - Chang, W. -. T. PY - 2004 DA - 2004// TI - Endoplasmic Reticulum Stress Stimulates the Expression of Cyclooxygenase-2 through Activation of NF-kB and pp 38 Mitogen-activated Protein Kinase JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M403568200 DO - 10.1074/jbc.M403568200 ID - Hung2004 ER - TY - JOUR AU - Hösel, M. AU - Quasdorff, M. AU - Wiegmann, K. AU - Webb, D. AU - Zedler, U. AU - Broxtermann, M. PY - 2009 DA - 2009// TI - Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection JO - Hepatology VL - 50 UR - https://doi.org/10.1002/hep.23226 DO - 10.1002/hep.23226 ID - Hösel2009 ER -